On December 23, 2014, Apotex Inc. and Mylan Pharmaceuticals ULC each filed Supreme Court of Canada (SCC) applications.
January 06, 2015
In April 2014, Health Canada launched its Regulatory Transparency and Openness Framework (“RTOF”).
Bill 21, Safeguarding Health Care Integrity Act, 2014, was proposed on July 22, 2014, and received Royal Assent on December 11, 2014.
Bill 28 – An Act mainly to implement certain provisions of the Budget Speech of 4 June 2014 and return to a balanced budget in 2015-2016 was tabled by Carlos Leitão.
January 05, 2015
A report from the Patented Medicine Prices Review Board (PMPRB) compares generic drug prices in Canada with those of other industrialized countries.
December 16, 2014
Bill C-8, the Combatting Counterfeit Products Act received Royal Assent on December 9, 2014.
December 12, 2014
On September 30, 2014, Health Canada took action to ban the import of finished drug products and active pharmaceutical ingredients.
December 03, 2014
Intellectual Property professionals, and owners of intellectual property (IP) rights, generally agree on the important value of patents.
December 02, 2014
Apotex Inc. (“Apotex”) had commenced an action for damages, including punitive damages, against Health Canada for its failure to issue a Notice of Compliance.
November 28, 2014
The Supreme Court of Canada has refused Teva’s application for leave to appeal the decision of the Federal Court of Appeal.
November 17, 2014
Try searching our global site instead